相关实验视频
Updated: Sep 15, 2025

08:54
Facile Preparation and Photoactivation of Prodrug-Dye Nanoassemblies
Published on: February 17, 2023
1.2K
阿克里顿产药具有增强的双阶段抗疟疾疗效
Rozalia A Dodean1,2, Yuexin Li2, Xiaowei Zhang2
1Department of Chemistry, Portland State University, Portland, Oregon 97201, United States.
ACS medicinal chemistry letters
|July 16, 2025
概括
一种新的前药物策略产生了强大的双阶段抗疟疾药物阿克里类型. 与其原始化合物T226相比,T235前药在感染疟疾的小鼠中显示出优异的口服疗效和激进治疗潜力.
科学领域:
- 药用化学 医学化学
- 寄生虫学的寄生虫学
- 药物开发 药物开发
背景情况:
- 疟疾仍然是一个重大的全球卫生挑战,需要开发新的抗疟疾药物.
- 现有的治疗方法面临诸如耐药性和寄生虫清除不完全等挑战,这凸显了需要彻底治愈策略的需要.
研究的目的:
- 开发和评估具有双阶段抗疟疾活性和彻底治愈潜力的新型基于阿克里的前期药物.
- 在临床前疟疾模型中评估领先前药物T235的口服疗效和预防能力.
主要方法:
- 合成含有碳酸盐前药物部分的阿克里类型.
- 在小鼠*Plasmodium yoelii*和*Plasmodium berghei*感染模型中评估抗疟疾活性.
- 通过不同的剂量方案评估口服疗效,激进治疗潜力和预防疗效.
主要成果:
- 与其原始化合物T226相比,前药T235显著提高了口服疗效.
- 在 *P. yoelii* 感染的小鼠中,T235 通过口服多天和单剂量进行了完全治愈.
- 在 *P. berghei* 感染的小鼠中,T235 提供了完整的肝脏阶段保护和持续的血液阶段治愈,在预防疗效方面表现优于T226.
结论:
- 以Acridone为基础的前期药物,例如T235,代表了开发高效的双阶段抗疟药的有希望的战略.
- 在疟疾治疗和预防方面,T235具有显著的潜力,提供了彻底的治愈和预防性益处.
- 这项研究为治疗疟疾的先进阿克里衍生物的临床开发铺平了道路.
相关概念视频
Prodrugs
3.0K
Prodrugs are a class of pharmaceutical compounds that undergo a biotransformation process within the body to be converted into a pharmacologically active drug. Prodrugs are designed to improve the therapeutic properties of the parent drug, such as enhancing bioavailability, increasing stability, or reducing toxicity. The concept of prodrugs revolves around modifying the chemical structure of the original drug to make it more effective or convenient for administration.
Prodrugs help overcome...
Prodrugs help overcome...
3.0K
Aryldiazonium Salts to Azo Dyes: Diazo Coupling
3.1K
The reaction of weakly electrophilic aryldiazonium (also called arenediazonium) salts with highly activated aromatic compounds leads to the formation of products with an —N=N— link, called an azo linkage. This reaction, presented in Figure 1, is known as diazo coupling and occurs without the loss of the nitrogen atoms of the aryldiazonium salt. Highly activated aromatic compounds such as phenols or arylamines favor the diazo coupling reaction. The coupling generally occurs at the...
3.1K
Indirect-Acting Cholinergic Agonists: Pharmacokinetics
1.1K
Indirect-acting cholinergic agonists, or anticholinesterases, enhance the body's cholinergic activity by inhibiting acetylcholine's breakdown. They are categorized as reversible or irreversible agents based on their mechanism of action. They are further classified into short-acting, intermediate-acting, and long-acting agents based on their duration of action.
Reversible agents containing quaternary amines, such as neostigmine and edrophonium, are not easily absorbed orally because they...
Reversible agents containing quaternary amines, such as neostigmine and edrophonium, are not easily absorbed orally because they...
1.1K
Adrenergic Agonists: Chemistry and Structure-Activity Relationship
3.3K
Adrenergic agonists' structure-activity relationship (SAR) determines their selectivity and efficacy. These agonists comprise a phenylethylamine moiety with an aromatic ring and an ethylamine side chain.
Aromatic ring substitutions: Substituting the aromatic ring with –OH groups at positions 3 and 4 yields catecholamines (e.g., epinephrine), which have a high affinity for adrenoceptors. Hydrogen bonding between –OH groups and receptors enhances adrenergic activity.
Separation of...
Aromatic ring substitutions: Substituting the aromatic ring with –OH groups at positions 3 and 4 yields catecholamines (e.g., epinephrine), which have a high affinity for adrenoceptors. Hydrogen bonding between –OH groups and receptors enhances adrenergic activity.
Separation of...
3.3K
Combined Effects of Drugs: Synergism
4.8K
Synergism is a useful mechanism where combining two or more drugs is more effective than each constituent used alone. Such combinations are also called supra-additive interactions. The drugs collectively enhance the final therapeutic effect by acting on different targets. Another advantage is that the low dose of each constituent drug is sufficient to achieve the desired effect. This helps reduce the duration of therapy and lower the adverse effects of these drugs.
Such synergistic combinations...
Such synergistic combinations...
4.8K
Direct-Acting Cholinergic Agonists: Pharmacokinetics
1.4K
Direct-acting cholinergic agonists, such as synthetic choline esters and naturally occurring alkaloids, exert their effects by enhancing the actions of acetylcholine and stimulating the parasympathetic nervous system. Synthetic choline esters share structural similarities with acetylcholine. For example, they have a positively charged quaternary ammonium or onium group, contributing to their hydrophilic characteristics. As a result, they are poorly absorbed in the body through oral...
1.4K

